1. Corporate Officers - L
2. Langer Robert

Insider Trading History of Langer Robert

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Langer Robert since 2007. This trader's CIK number is 1239757. At the time of last reporting, Langer Robert was the Director of Moderna, Inc.. (stock ticker symbol MRNA). Also see all insider trading activities at Moderna, Inc..

Note that in the past LANGER ROBERT also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Moderna, Inc. (MRNA) by Langer Robert

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2022	MRNA	0	$0	0	$0	703	$0

Yearly summary of insider trading at Momenta Pharmaceuticals Inc (MNTA) by Langer Robert

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2008	MNTA	0	$0	20,000	$336,200	0	$0

Yearly summary of insider trading at Bind Therapeutics, Inc (BIND) by Langer Robert

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2016	BIND	0	$0	0	$0	15,000	$6,600

Yearly summary of insider trading at Sontra Medical Corp (SONT) by Langer Robert

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2007	SONT	250,000	$25,000	0	$0	0	$0

Yearly summary of insider trading at Invivo Therapeutics Holdings Corp. (NVIV) by Langer Robert

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2013	NVIV	0	$0	265,735	$699,770	0	$0
2012	NVIV	0	$0	565,247	$1,369,420	0	$0

Yearly summary of insider trading at Rubius Therapeutics, Inc. (RUBY) by Langer Robert

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2019	RUBY	0	$0	30,000	$417,171	30,000	$4,500

Insider trading activities at 6 companies by Langer Robert:

1. Moderna, Inc. (MRNA)

2. Momenta Pharmaceuticals Inc (MNTA)

3. Bind Therapeutics, Inc (BIND)

4. Sontra Medical Corp (SONT)

5. Invivo Therapeutics Holdings Corp. (NVIV)

6. Rubius Therapeutics, Inc. (RUBY)

Table 1. Insider trading of Moderna, Inc. (MRNA) by Langer Robert

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2022-04-28	MRNA	Option Ex	703	.00	0

Table 2. Insider trading of Momenta Pharmaceuticals Inc (MNTA) by Langer Robert

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2008-08-08	MNTA	Sale	20,000	16.81	336,200

Table 3. Insider trading of Bind Therapeutics, Inc (BIND) by Langer Robert

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2016-08-26	BIND	Option Ex	15,000	.44	6,600

Table 4. Insider trading of Sontra Medical Corp (SONT) by Langer Robert

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2007-01-30	SONT	Buy	250,000	.10	25,000

Table 5. Insider trading of Invivo Therapeutics Holdings Corp. (NVIV) by Langer Robert

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2013-06-04	NVIV	Sale	2,500	3.90	9,755
2013-06-03	NVIV	Sale	2,500	3.37	8,432
2013-06-05	NVIV	Sale	2,500	3.91	9,775
2013-05-31	NVIV	Sale	2,500	3.39	8,475
2013-05-30	NVIV	Sale	2,500	3.40	8,500
2013-05-29	NVIV	Sale	2,500	3.13	7,825
2013-05-24	NVIV	Sale	2,500	2.97	7,420
2013-05-28	NVIV	Sale	2,500	3.03	7,570
2013-05-23	NVIV	Sale	2,500	2.90	7,250
2013-05-22	NVIV	Sale	2,500	2.89	7,220
2013-05-21	NVIV	Sale	2,500	2.87	7,180
2013-05-20	NVIV	Sale	2,500	2.88	7,210
2013-05-15	NVIV	Sale	2,500	2.85	7,115
2013-05-16	NVIV	Sale	2,500	2.84	7,090
2013-05-17	NVIV	Sale	2,500	2.86	7,157
2013-05-13	NVIV	Sale	2,500	3.00	7,500
2013-05-14	NVIV	Sale	2,500	2.85	7,125
2013-05-10	NVIV	Sale	2,500	2.90	7,237
2013-05-07	NVIV	Sale	2,500	2.94	7,337
2013-05-08	NVIV	Sale	2,500	2.86	7,145
2013-05-09	NVIV	Sale	2,500	2.94	7,337
2013-05-02	NVIV	Sale	2,500	3.05	7,625
2013-05-03	NVIV	Sale	2,500	3.02	7,550
2013-05-06	NVIV	Sale	2,500	3.00	7,510
2013-04-30	NVIV	Sale	2,500	3.19	7,985
2013-04-29	NVIV	Sale	2,500	2.99	7,485
2013-05-01	NVIV	Sale	2,500	3.17	7,920
2013-04-24	NVIV	Sale	2,500	2.96	7,405
2013-04-25	NVIV	Sale	2,500	2.94	7,360
2013-04-26	NVIV	Sale	2,500	2.85	7,127
2013-01-17	NVIV	Sale	52,425	2.46	129,070
2013-01-16	NVIV	Sale	102,874	2.46	253,481
2013-01-15	NVIV	Sale	35,436	2.47	87,597
2012-06-29	NVIV	Sale	24,780	2.31	57,167
2012-07-02	NVIV	Sale	20,220	2.39	48,265
2012-06-27	NVIV	Sale	13,450	2.40	32,280
2012-06-26	NVIV	Sale	126,550	2.42	306,251
2012-06-28	NVIV	Sale	15,000	2.30	34,560
2012-04-13	NVIV	Sale	40,160	2.39	95,982
2012-04-16	NVIV	Sale	159,840	2.40	383,616
2011-12-29	NVIV	Sale	165,247	2.49	411,299

Table 6. Insider trading of Rubius Therapeutics, Inc. (RUBY) by Langer Robert

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2019-10-14	RUBY	Option Ex	7,500	.15	1,125
2019-10-14	RUBY	Sale	7,500	8.52	63,877
2019-07-15	RUBY	Option Ex	7,500	.15	1,125
2019-07-15	RUBY	Sale	7,500	14.94	112,050
2019-04-15	RUBY	Option Ex	7,500	.15	1,125
2019-04-15	RUBY	Sale	7,500	17.57	131,797
2019-01-14	RUBY	Sale	7,500	14.59	109,447
2019-01-14	RUBY	Option Ex	7,500	.15	1,125

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Langer Robert (Director of Moderna, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month